Seres Therapeutics, Inc. ( MCRB) - Key Metrics
MCRB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.04 | $0.94 | $0.25 | $0.25 |
| 2025Q2 | ? | -$2.27 | -$1.52 | -$1.54 |
| 2025Q1 | ? | $3.76 | $3.09 | $3.09 |
MCRB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | 5.14 |
| 2025Q2 | ? | -1.22 |
| 2025Q1 | ? | 0.93 |
MCRB
Price: $6.61
52 week price:
Earnings Per Share: -5.20 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 536116
Ebitda: -5.4 millionMarket Capitalization: 69.7 million